Calcineurin-regulated NFAT-dependent transcription in lymphocytes

No Pathway Network information available for Calcineurin-regulated NFAT-dependent transcription in lymphocytes

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

Disorders associated with Calcineurin-regulated NFAT-dependent transcription in lymphocytes SuperPath

according to GeneCards Suite gene sharing
#DisorderTypeGenesScore
1Congenital generalized lipodystrophyEnrichmentFOS, PPARG4.21
2Type 1 diabetes mellitus 10EnrichmentIL2RA2.77
3Immunodeficiency 69EnrichmentIFNG2.77
4Immunodeficiency with hyper-igm, type 1EnrichmentCD40LG2.77
5Pigmented nodular adrenocortical disease, primary, 4EnrichmentPRKACA2.77
6Cardioacrofacial dysplasia 1EnrichmentPRKACA2.77
7Spastic ataxia 9, autosomal recessiveEnrichmentCHP12.77
8Cd40 ligand deficiencyEnrichmentCD40LG2.77
9Immunodysregulation, polyendocrinopathy, and enteropathy, x-linkedEnrichmentFOXP32.49
10Cataract 21, multiple typesEnrichmentMAF2.49
11Charcot-marie-tooth disease, demyelinating, type 1dEnrichmentEGR22.49
12Melanoma, cutaneous malignant 3EnrichmentCDK42.49
13Skin/hair/eye pigmentation, variation in, 8EnrichmentIRF42.49
14Celiac disease 3EnrichmentCTLA42.49
15Immunodeficiency 131EnrichmentIRF42.49
16Type 1 diabetes mellitus 12EnrichmentCTLA42.49
17Ayme-gripp syndromeEnrichmentMAF2.49
18Autoimmune disease, multisystem, with facial dysmorphismEnrichmentITCH2.49
19Immunodeficiency, common variable, 13EnrichmentIKZF12.49
20Immunodeficiency 88EnrichmentTBX212.49
21Pparg-associated congenital generalized lipodystrophyEnrichmentPPARG2.49
22Combined immunodeficiency due to dimerization defective ikaros mutationEnrichmentIKZF12.49
23Syndromic multisystem autoimmune disease due to itch deficiencyEnrichmentITCH2.49
24Charcot-marie-tooth disease type 1dEnrichmentEGR22.49
25Early-onset combined immunodeficiency with low ig due to dominant negative ikaros mutationEnrichmentIKZF12.49
26Whipple diseaseEnrichmentIRF42.49
27Immunodeficiency 41 with lymphoproliferation and autoimmunityEnrichmentIL2RA2.47
28Fibrolamellar carcinomaEnrichmentPRKACA2.47
29Joint contractures, osteochondromas, and b-cell lymphomaEnrichmentNFATC22.47
30Tuberous sclerosis 1EnrichmentIFNG2.29
31Immunodeficiency 98 with autoinflammation, x-linkedEnrichmentFASLG2.29
32Hepatitis c virusEnrichmentIFNG2.29
33Tuberous sclerosis 2EnrichmentIFNG2.29
34Hashimoto thyroiditisEnrichmentCTLA42.19
35Hypoparathyroidism, sensorineural deafness, and renal dysplasia syndromeEnrichmentGATA32.19
36Multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephalyEnrichmentFOXP32.19
37Carotid intimal medial thickness 1EnrichmentPPARG2.19
38Neuropathy, congenital hypomyelinating, 1, autosomal recessiveEnrichmentEGR22.19
39Developmental and epileptic encephalopathy 28EnrichmentMAF2.19
40Spinocerebellar ataxia, autosomal recessive 12EnrichmentMAF2.19
41Diamond-blackfan anemia-likeEnrichmentIKZF12.19
42Autoimmune disease, multisystem, infantile-onset, 3EnrichmentCBLB2.19
43Immunodeficiency 127EnrichmentTNF2.19
44Stevens-johnson syndromeEnrichmentIKZF12.19
45B-lymphoblastic leukemia/lymphoma with hyperdiploidyEnrichmentGATA32.19
46Hypoparathyroidism-deafness-renal disease syndromeEnrichmentGATA32.19
47Familial partial lipodystrophyEnrichmentPPARG2.19
48Autosomal dominant nonsyndromic deafnessEnrichmentGATA32.19
49Autoimmune lymphoproliferative syndromeEnrichmentFASLG2.17
50Systemic lupus erythematosusEnrichmentCTLA4, TNF2.15
51Breast cancerEnrichmentIL2, JUN2.15
52Type 2 diabetes mellitusEnrichmentPPARG, PTPN12.09
53Histiocytoid hemangiomaEnrichmentFOS2.07
54Idiopathic aplastic anemiaEnrichmentIFNG2.07
55Asthma, nasal polyps, and aspirin intoleranceEnrichmentTBX212.01
56Mycosis fungoidesEnrichmentCTLA42.01
57Psoriatic arthritisEnrichmentTNF2.01
58Immune dysregulation with autoimmunity, immunodeficiency, and lymphoproliferationEnrichmentCTLA42.01
59Dedifferentiated liposarcomaEnrichmentCDK42.01
60Asparagine synthetase deficiencyEnrichmentCTLA42.01
61Migraine without auraEnrichmentTNF2.01
62Charcot-marie-tooth disease type 1EnrichmentEGR22.01
63End stage renal diseaseEnrichmentGATA32.01
64Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndromeEnrichmentCTLA42.01
65Adult-onset myasthenia gravisEnrichmentCTLA42.01
66Well-differentiated liposarcomaEnrichmentCDK42.01
67Saczary syndromeEnrichmentCTLA42.01
68Common variable immunodeficiencyEnrichmentCD40LG1.93
69Oligoarticular juvenile idiopathic arthritisEnrichmentIL2RA1.93
70Rheumatoid factor-negative juvenile idiopathic arthritisEnrichmentIL2RA1.93
71Lipodystrophy, familial partial, type 3EnrichmentPPARG1.89
72Immunodeficiency, common variable, 1EnrichmentCTLA41.89
73Leptin deficiency or dysfunctionEnrichmentPPARG1.89
74Congenital blue dot cataractEnrichmentMAF1.89
75Cerebral malariaEnrichmentTNF1.89
76Ellis-van creveld syndromeEnrichmentPRKACA1.82
77Hypertrophic neuropathy of dejerine-sottasEnrichmentEGR21.79
78Vascular dementiaEnrichmentTNF1.79
79Aplastic anemiaEnrichmentIFNG1.77
80Type 1 diabetes mellitusEnrichmentFOXP31.71
81Granulomatosis with polyangiitisEnrichmentCTLA41.71
82B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)EnrichmentIKZF11.65
83Cataract - microcornea syndromeEnrichmentMAF1.59
84Inflammatory bowel disease 1EnrichmentPRKCQ1.54
85Hydrops fetalisEnrichmentFOXP31.54
86Human immunodeficiency virus type 1EnrichmentIFNG1.52
87Cataract 30, multiple typesEnrichmentMAF1.50
88Cardiomyopathy, dilated, 1aEnrichmentNFATC21.46
89Immune deficiency diseaseEnrichmentIKZF11.45
90AsthmaEnrichmentTNF1.45
91Leukemia, acute lymphoblasticEnrichmentIKZF11.45
92Alzheimer's diseaseEnrichmentTNF1.38
93GliosarcomaEnrichmentPPARG1.30
94Lung cancerEnrichmentFASLG1.28
95Melanoma, cutaneous malignant 1EnrichmentCDK41.27
96Giant cell glioblastomaEnrichmentPPARG1.27
97Charcot-marie-tooth disease type 4EnrichmentEGR21.25
98Centronuclear myopathyEnrichmentFOXP31.18
99MalariaEnrichmentTNF1.14
100Developmental and epileptic encephalopathy 1EnrichmentMAF1.11
101Differentiated thyroid carcinomaEnrichmentPPARG1.05
102CakutEnrichmentGATA30.98
103Benign epilepsy with centrotemporal spikesEnrichmentMAF0.90
104Centralopathic epilepsyEnrichmentMAF0.88
105Gastric cancerEnrichmentCDK40.88
106West syndromeEnrichmentMAF0.87
107Body mass index quantitative trait locus 11EnrichmentPPARG0.82
108Colorectal cancerEnrichmentPPARG0.61
109Inherited cancer-predisposing syndromeEnrichmentCDK40.46

Loading...
Loading...
Loading...